Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC.SXTP · Entity 8389 | Director | June 03, 2025 | June 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
60 DEGREES PHARMACEUTICALS, INC.
Report date June 03, 2025 · Filed June 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,816 |
Last balance in matching sequence
After 2025-06-03 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-06-03 · Purchase · Acquired 3,000 · Balance 13,816 F1: Reflects a 1-for-5 reverse stock split effective February 24, 2025, resulting in the reporting person's beneficial ownership being adjusted from 54,078 shares to 10,816 shares. Fractional shares were rounded up to the nearest whole share Row 2 · 2025-06-03 · Purchase · Acquired 2,000 · Balance 15,816 F1: Reflects a 1-for-5 reverse stock split effective February 24, 2025, resulting in the reporting person's beneficial ownership being adjusted from 54,078 shares to 10,816 shares. Fractional shares were rounded up to the nearest whole share |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a 1-for-5 reverse stock split effective February 24, 2025, resulting in the reporting person's beneficial ownership being adjusted from 54,078 shares to 10,816 shares. Fractional shares were rounded up to the nearest whole share
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2025 Filed Jun 6, 2025 00:53 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 2,000 | $2.90 | $5,800.00 |
DisclosureSEC source: 0001213900-25-051700 · ownership.xml · nonDerivative · entry 2 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,816 F1 · balance_after: Reflects a 1-for-5 reverse stock split effective February 24, 2025, resulting in the reporting person's beneficial ownership being adjusted from 54,078 shares to 10,816 shares. Fractional shares were rounded up to the nearest whole share Read SEC document |
| June 03, 2025 Filed Jun 6, 2025 00:53 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 3,000 | $2.87 | $8,610.00 |
DisclosureSEC source: 0001213900-25-051700 · ownership.xml · nonDerivative · entry 1 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,816 F1 · balance_after: Reflects a 1-for-5 reverse stock split effective February 24, 2025, resulting in the reporting person's beneficial ownership being adjusted from 54,078 shares to 10,816 shares. Fractional shares were rounded up to the nearest whole share Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 01:35 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 2,000 | $1.45 | $2,900.00 |
DisclosureSEC source: 0001213900-24-110269 · ownership.xml · nonDerivative · entry 7 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,078 Read SEC document |
| December 13, 2024 Filed Dec 19, 2024 01:35 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 1,500 | $1.52 | $2,280.00 |
DisclosureSEC source: 0001213900-24-110269 · ownership.xml · nonDerivative · entry 6 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,078 Read SEC document |
| December 13, 2024 Filed Dec 19, 2024 01:35 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 1,500 | $1.55 | $2,325.00 |
DisclosureSEC source: 0001213900-24-110269 · ownership.xml · nonDerivative · entry 5 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,578 Read SEC document |
| December 13, 2024 Filed Dec 19, 2024 01:35 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 1,500 | $1.58 | $2,370.00 |
DisclosureSEC source: 0001213900-24-110269 · ownership.xml · nonDerivative · entry 4 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,078 Read SEC document |
| December 13, 2024 Filed Dec 19, 2024 01:35 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 1,500 | $1.60 | $2,400.00 |
DisclosureSEC source: 0001213900-24-110269 · ownership.xml · nonDerivative · entry 3 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,578 Read SEC document |
| December 12, 2024 Filed Dec 19, 2024 01:35 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 2,500 | $1.80 | $4,500.00 |
DisclosureSEC source: 0001213900-24-110269 · ownership.xml · nonDerivative · entry 2 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,078 Read SEC document |
| December 12, 2024 Filed Dec 19, 2024 01:35 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 2,500 | $1.85 | $4,625.00 |
DisclosureSEC source: 0001213900-24-110269 · ownership.xml · nonDerivative · entry 1 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,578 Read SEC document |
| August 27, 2024 Filed Sep 11, 2024 20:46 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 5,000 | $1.70 | $8,500.00 |
DisclosureSEC source: 0001213900-24-077746 · ownership.xml · nonDerivative · entry 1 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,078 F1 · balance_after: Adjusted for the Issuer's 1-for-12 reverse stock split effected on August 12, 2024. Read SEC document |
| May 16, 2024 Filed May 22, 2024 00:23 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | Exercise / conversionRestricted Stock Unit · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-045709 · ownership.xml · derivative · entry 2 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: A total of 8,000 restricted stock units ("RSUs") were initially granted to Ms. Xu on July 11, 2023, of which were subsequently modified to 4,000 RSUs and fully vested as of December 31, 2023. Each RSU represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: A total of 8,000 restricted stock units ("RSUs") were initially granted to Ms. Xu on July 11, 2023, of which were subsequently modified to 4,000 RSUs and fully vested as of December 31, 2023. Each RSU represents the right to receive, at settlement, one share of common stock. F2 · derivative.expiration_date: A total of 8,000 restricted stock units ("RSUs") were initially granted to Ms. Xu on July 11, 2023, of which were subsequently modified to 4,000 RSUs and fully vested as of December 31, 2023. Each RSU represents the right to receive, at settlement, one share of common stock. F2 · balance_after: A total of 8,000 restricted stock units ("RSUs") were initially granted to Ms. Xu on July 11, 2023, of which were subsequently modified to 4,000 RSUs and fully vested as of December 31, 2023. Each RSU represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 16, 2024 Filed May 22, 2024 00:23 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | Exercise / conversionCommon Stock | 2,000 | $0.22 | $446.00 |
DisclosureSEC source: 0001213900-24-045709 · ownership.xml · nonDerivative · entry 1 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction represents the settlement of restricted stock units in shares of common stock on May 16, 2024. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 20:31 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | Exercise / conversionCommon Stock | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-24-009599 · ownership.xml · nonDerivative · entry 2 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Ms. Xu was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. A total of 8,000 RSUs were granted to Ms. Xu on July 11, 2023 and vest in equal quarterly installments for a period of 12 months. As of the date of this filing, a total of 6,000 RSUs have vested. F1 · price: Ms. Xu was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. A total of 8,000 RSUs were granted to Ms. Xu on July 11, 2023 and vest in equal quarterly installments for a period of 12 months. As of the date of this filing, a total of 6,000 RSUs have vested. F1 · balance_after: Ms. Xu was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. A total of 8,000 RSUs were granted to Ms. Xu on July 11, 2023 and vest in equal quarterly installments for a period of 12 months. As of the date of this filing, a total of 6,000 RSUs have vested. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:31 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseWarrant · Derivative | 200,000 | $0.01 Strike: $0.42 | $2,000.00 |
DisclosureSEC source: 0001213900-24-009599 · ownership.xml · derivative · entry 3 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-01-31 Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:31 UTC | 60 DEGREES PHARMACEUTICALS, INC. SXTP · Entity 8389 | PurchaseCommon Stock | 200,000 | $0.38 | $75,000.00 |
DisclosureSEC source: 0001213900-24-009599 · ownership.xml · nonDerivative · entry 1 XU CHERYL · CIK 0001976957 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,934 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.